Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 706 (ZNF706) is a member of the C2H2-type zinc finger transcription factor family and is encoded by the ZNF706 gene located at chromosome 8q22.3[1][2][6]. It is primarily localized in the nucleus and acts as a transcriptional repressor, involved in regulating gene expression by binding DNA through its C-terminal zinc finger domain[1][6]. ZNF706 is implicated in repressing the expression of KLF4 and the exit of embryonic stem cells from self-renewal[2][6]. Experimentally, ZNF706 has been identified as an oncogenic factor in several cancers, most notably hepatocellular carcinoma, where its overexpression predicts poor patient survival[1]. It regulates sensitivity to ferroptosis through transcriptional activation of the SLC7A11 gene, impacting redox homeostasis in cancer cells[1]. While no direct drug interactions are currently reported, ZNF706 represents a potential therapeutic target, particularly in cancer. Elevated ZNF706 expression is considered a potential prognostic biomarker in liver cancer[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 706 (ZNF706).